Regulatory UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition Pharmaceutical TechnologyThe MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.Metabolic & GLP-1Read full story pharminent August 11, 2026 (Last updated: August 14, 2026) Pharmaceutical Technology The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU. Metabolic & GLP-1 Read full story Post navigation Previous: BMS banks on Texas for $2.3bn multi-modal manufacturing facilityNext: Trump signs order that nearly halves childhood immunisation coverage Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026